Logo image of ISPC

ISPECIMEN INC (ISPC) Stock Fundamental Analysis

NASDAQ:ISPC - Nasdaq - US45032V2079 - Common Stock - Currency: USD

1.75  -0.06 (-3.31%)

Fundamental Rating

3

Overall ISPC gets a fundamental rating of 3 out of 10. We evaluated ISPC against 39 industry peers in the Health Care Technology industry. ISPC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ISPC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ISPC had negative earnings in the past year.
In the past year ISPC has reported a negative cash flow from operations.
In the past 5 years ISPC always reported negative net income.
In the past 5 years ISPC always reported negative operating cash flow.
ISPC Yearly Net Income VS EBIT VS OCF VS FCFISPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

ISPC has a worse Return On Assets (-84.55%) than 81.08% of its industry peers.
ISPC has a Return On Equity of -202.01%. This is in the lower half of the industry: ISPC underperforms 75.68% of its industry peers.
Industry RankSector Rank
ROA -84.55%
ROE -202.01%
ROIC N/A
ROA(3y)-45.63%
ROA(5y)-64.82%
ROE(3y)-64.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISPC Yearly ROA, ROE, ROICISPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 400 600 800

1.3 Margins

With a Gross Margin value of 47.97%, ISPC perfoms like the industry average, outperforming 40.54% of the companies in the same industry.
ISPC's Gross Margin has improved in the last couple of years.
ISPC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.92%
GM growth 5Y2.16%
ISPC Yearly Profit, Operating, Gross MarginsISPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

ISPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ISPC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ISPC has been reduced compared to 5 years ago.
ISPC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ISPC Yearly Shares OutstandingISPC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ISPC Yearly Total Debt VS Total AssetsISPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ISPC has an Altman-Z score of -10.13. This is a bad value and indicates that ISPC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ISPC (-10.13) is worse than 83.78% of its industry peers.
There is no outstanding debt for ISPC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.13
ROIC/WACCN/A
WACC10.3%
ISPC Yearly LT Debt VS Equity VS FCFISPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.74 indicates that ISPC may have some problems paying its short term obligations.
ISPC has a Current ratio of 0.74. This is amonst the worse of the industry: ISPC underperforms 81.08% of its industry peers.
ISPC has a Quick Ratio of 0.74. This is a bad value and indicates that ISPC is not financially healthy enough and could expect problems in meeting its short term obligations.
ISPC has a Quick ratio of 0.74. This is amonst the worse of the industry: ISPC underperforms 81.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
ISPC Yearly Current Assets VS Current LiabilitesISPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

ISPC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.26%, which is quite good.
The Revenue has been growing slightly by 0.69% in the past year.
The Revenue has been growing by 17.73% on average over the past years. This is quite good.
EPS 1Y (TTM)17.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.35%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y6.67%
Revenue growth 5Y17.73%
Sales Q2Q%-4.24%

3.2 Future

The Earnings Per Share is expected to grow by 40.24% on average over the next years. This is a very strong growth
ISPC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.14% yearly.
EPS Next Y96.29%
EPS Next 2Y40.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.58%
Revenue Next 2Y9.14%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ISPC Yearly Revenue VS EstimatesISPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ISPC Yearly EPS VS EstimatesISPC Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ISPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ISPC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ISPC Price Earnings VS Forward Price EarningsISPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPC Per share dataISPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

ISPC's earnings are expected to grow with 40.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.24%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ISPC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPECIMEN INC

NASDAQ:ISPC (2/21/2025, 11:32:40 AM)

1.75

-0.06 (-3.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners2.44%
Inst Owner Change-57.88%
Ins Owners14.3%
Ins Owner Change0%
Market Cap1.68M
Analysts82.86
Price TargetN/A
Short Float %4.73%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-475.06%
Min EPS beat(2)-983.59%
Max EPS beat(2)33.47%
EPS beat(4)1
Avg EPS beat(4)-249.26%
Min EPS beat(4)-983.59%
Max EPS beat(4)33.47%
EPS beat(8)4
Avg EPS beat(8)-116.8%
EPS beat(12)5
Avg EPS beat(12)-70.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.04%
Min Revenue beat(2)-11.51%
Max Revenue beat(2)-2.56%
Revenue beat(4)0
Avg Revenue beat(4)-13.03%
Min Revenue beat(4)-21.06%
Max Revenue beat(4)-2.56%
Revenue beat(8)3
Avg Revenue beat(8)-7.45%
Revenue beat(12)4
Avg Revenue beat(12)-9.22%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-18.7
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-6.24
FCFYN/A
OCF(TTM)-4.53
OCFYN/A
SpS10.82
BVpS4.91
TBVpS-1.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -84.55%
ROE -202.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.97%
FCFM N/A
ROA(3y)-45.63%
ROA(5y)-64.82%
ROE(3y)-64.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.92%
GM growth 5Y2.16%
F-Score3
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.92%
Cap/Sales 15.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z -10.13
F-Score3
WACC10.3%
ROIC/WACCN/A
Cap/Depr(3y)197.71%
Cap/Depr(5y)192.03%
Cap/Sales(3y)29.27%
Cap/Sales(5y)27.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.35%
EPS Next Y96.29%
EPS Next 2Y40.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y6.67%
Revenue growth 5Y17.73%
Sales Q2Q%-4.24%
Revenue Next Year6.58%
Revenue Next 2Y9.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.25%
OCF growth 3YN/A
OCF growth 5YN/A